Stanley Liauw, MD

Associate Professor of Radiation & Cellular Oncology

Dr. Stanley Liauw oversees the genitourinary cancer program and the gastrointestinal cancer program within the Department of Radiation and Cellular Oncology. Since joining the faculty in 2006, Dr. Liauw has implemented several programmatic changes in prostate and gastrointestinal radiation therapy.

Dr. Liauw's primary research interests include clinical outcomes and clinical trials. He oversees the management of several clinical databases which track patient outcomes for more than 2000 patients. The information collected is used to identify factors that are associated with treatment success and quality of life.

Dr. Liauw is the primary investigator of several clinical trials involving genitourinary and gastrointestinal radiation therapy. These include protocols regarding gene therapy for prostate cancer, bladder preserving treatment for patients with bladder cancer, and stereotactic body radiation therapy for patients with pancreatic cancer.

Dr. Liauw has been the recipient of several research and training awards. He has presented his work at national scientific meetings, and has published manuscripts in a variety of medical journals.

Year Started Practice

2006

Board Certification

Radiation Oncology

Specialty

Radiation Oncology

Medical School

University of Texas Southwestern Medical School, Dallas

Internship

Brigham and Women's Hospital, Boston

Residency

Shands at the University of Florida, Gainesville, FL

Language Spoken

English

Office Phone

(773) 702-6870

Office Fax

(773) 834-7340

Office Postal Address

Stanley Liauw, MD
The University of Chicago Medicine
5758 S. Maryland Ave. MC 9006
Chicago, IL 60637

Clinical Interests

• Genitourinary cancers
• Gastrointestinal cancers
• Prostate brachytherapy
• Clinical trials

Request an appointment online
or call UCM Connect at
1-888-824-0200

Selected Publications

View a list of Dr. Liauw's publications through the National Library of Medicine's PubMed online database.